Lead Sponsor

Wellspect HealthCare

Age

45 - 85 years

Sex

MALE

Healthy Volunteers

No

•Provision of informed consent
•Males aged 45-85 years
•\>60% of the voiding volume is above 100 ml per voiding verified by a urinary diary
•Able to read write and understand given instructions

•Patients practicing CIC
•Ongoing symptomatic UTI
•Known Neurological Disease that is affecting the bladder function
•Known past or present alcohol or drug abuse
•Involvement in the planning and conduct of the study (applies to both Astra Tech staff or staff at the study site)
•Previous enrolment or randomisation of treatment in the present study.
•Suspected poor compliance based on less than 80 % compliance to voiding diary
•Severe non-compliance to protocol as judged by the investigator and/or Astra Tech
•On alpha-blocker or 5-alpha reductase inhibitor treatment, treatment started less than 2 months prior to enrolment
•Clinic flow below 100 ml

Related studies

NCT05989646 · Urinary Incontinence, Daytime Wetting, and more

NCT06798311 · Urinary Incontinence (UI), Lower Urinary Tract Symptoms (LUTS), and more

NCT07451548 · Lower Urinary Tract Symptoms (LUTS)

NCT03281798 · Lower Urinary Tract Obstructive Syndrome, Lower Urinary Tract Obstruction, Congenital, and more

NCT07187180 · BPH With Symptomatic Lower Urinary Tract Symptoms, BPH With Urinary Obstruction

The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects